Phase II study of gefitinib in combination with docetaxel as first-line therapy in metastatic breast cancer.
Ciardiello F, Troiani T, Caputo F, De Laurentiis M, Tortora G, Palmieri G, De Vita F, Diadema MR, Orditura M, Colantuoni G, Gridelli C, Catalano G, De Placido S, Bianco AR.
Ciardiello F, et al. Among authors: troiani t.
Br J Cancer. 2006 Jun 5;94(11):1604-9. doi: 10.1038/sj.bjc.6603141.
Br J Cancer. 2006.
PMID: 16685276
Free PMC article.
Clinical Trial.